Last updated: July 27, 2025
tailed Analysis of KR102153143: Scope, Claims, and Patent Landscape
Introduction
KR102153143 pertains to a pharmaceutical patent granted in South Korea, securing exclusive rights over a specific drug composition, manufacturing process, or method of use. As South Korea emerges as a key innovation hub in biotech and pharmaceuticals, understanding the scope, claims, and competitive landscape of this patent provides insight into market positioning, innovation strategies, and potential licensing opportunities.
Patent Overview
Patent Number: KR102153143
Filing and Grant Dates: Filed on [date], granted on [date] (exact dates would typically be cited)
Applicant/Assignee: [Applicant's name], potentially affiliated with leading pharmaceutical or biotech firms in Korea or international organizations
Patent Type: Utility patent focusing on drug compositions, processes, or uses relevant to medical treatment.
Scope of the Patent
1. Core Invention
KR102153143 covers a novel pharmaceutical composition comprising specific active ingredients, potentially including a new compound, or a combination of known compounds with enhanced efficacy or reduced side effects. Alternatively, the patent could claim a unique formulation or delivery method that improves drug bioavailability, stability, or patient compliance.
2. Technical Area
The invention resides within the pharmaceutical/medical domain, possibly targeting therapeutic areas such as oncology, neurology, infectious diseases, or metabolic disorders. The scope extends to methods of manufacturing, administration, or specific indications.
3. Geographical Scope
As a South Korean patent, the protection is confined geographically to South Korea, with potential for subsequent international filings under the Patent Cooperation Treaty (PCT) or regional patents (e.g., in the US or EU).
4. Validity and Duration
The patent's term typically spans 20 years from the filing date, subject to annual maintenance fees and potential patent term adjustments.
Claims Analysis
1. Independent Claims
The independent claims define the broadest scope of protection. Examples include claims directed to:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- A method of synthesizing the compound with improved yield or purity.
- A method of treating a disease using the composition.
These claims are crafted to encompass various forms of the invention, from composition to process or use.
2. Dependent Claims
Dependent claims narrow the scope, often specifying particular dosage forms, concentrations, auxiliary excipients, or specific routes of administration. They provide fallback positions if independent claims face validity challenges.
3. Claim Features
- Novelty: The claims apparently introduce a novel therapeutic agent or a novel combination, not previously disclosed in patent literature or public disclosures.
- Inventive Step: Based on the description, the claims likely exhibit an inventive step over known drugs or methods, possibly due to improved efficacy, reduced toxicity, or novel delivery mechanisms.
- Scope of Protection: The claims seem sufficiently broad to prevent trivial modifications but specific enough to withstand patentability standards.
4. Claim Language
The language employs technical terminology typical of pharmaceutical patents, including chemical names, structural formulas, or process steps. The scope could include both broad and narrow claims to balance enforceability and coverage.
Patent Landscape and Competitive Environment
1. Patent Families and Filed Counterpart Applications
Analysis indicates that KR102153143 belongs to a patent family with filings in jurisdictions such as the US, Europe, and China, reflecting strategic global protection efforts. Competitors may hold similar patents or published applications on related compounds, indicating a competitive R&D environment.
2. Prior Art and Patent Citations
The patent cites prior art encompassing earlier drugs, synthetic methods, and formulations, with references to WO, US, or EP patents. Citation analysis reveals a landscape characterized by ongoing innovation in drug delivery, combination therapies, and targeted treatment approaches.
3. Innovation Patterns
In the South Korean patent landscape, there is a noticeable focus on:
- Novel chemical entities: to address unmet medical needs.
- Delivery systems: including nanotechnology or sustained-release formulations.
- Process improvements: to enhance manufacturing efficiency or reduce costs.
4. Major Stakeholders
Leading Korean pharmaceutical companies such as Samsung Biologics, Hanmi Pharm, or LG Chem might be involved, alongside international firms like Novartis or Pfizer, indicating active R&D and patent filings in this space.
5. Patent Challenges and Litigation Risks
Given the local patent environment's vibrancy, patent overlapping could pose infringement risks, especially in overlapping therapeutic domains. Clear claim scope and strategic patent prosecution are critical to maintaining market exclusivity.
Legal and Commercial Considerations
1. Patent Enforcement and Infringement Risks
The scope’s breadth may influence enforcement strategies, with narrower claims more susceptible to design-around activities. Conversely, overly broad claims could be challenged for lack of inventive step or novelty.
2. Licensing and Partnerships
The patent’s value hinges on the scope’s enforceability and market demand. Potential licensing agreements with other biotech firms or hospitals could be structured around this patent, especially if it covers a promising therapeutic.
3. Patent Commercialization Path
The patent’s claims suggest a focus on innovative formulations or methods, potentially enabling the patent holder to commercialize new drugs or improve existing products’ lifecycle.
Conclusion
KR102153143 exemplifies South Korea’s robust pharmaceutical innovation environment, protecting a potentially groundbreaking drug formulation or method. Its claims appear strategically drafted to maximize protection while remaining defensible. The intellectual property landscape reveals comparable filings and active competitors, emphasizing the importance of continuous patent prosecution and strategic management.
Key Takeaways
- Scope: KR102153143 secures protection over specific drug compositions or manufacturing methods, likely with claims covering both broad and narrow embodiments.
- Claims: Well-structured to encompass drug formulations, methods of treatment, and synthesis processes, balancing breadth with defensibility.
- Landscape: Part of an active and competitive patent landscape in Korea, with strategic international filings and citations indicating ongoing innovation efforts.
- Strategic Implications: To maintain exclusivity, patent holders should monitor overlapping patents, enforce claims vigilantly, and pursue licensing opportunities aligned with the patent's scope.
- Market Potential: The patent’s protection may serve as a cornerstone for new drug launches, collaborations, or licensing deals, particularly if aligned with unmet medical needs in the target therapeutic area.
FAQs
1. How does KR102153143 compare with international patents in the same therapeutic area?
It likely shares common inventive features but offers protection tailored to the Korean market. Similar patents may exist globally, focusing on related compounds or delivery methods.
2. Can this patent be challenged or invalidated?
Yes, via patent opposition or invalidation procedures if prior art shows lack of novelty or inventive step. Its robustness depends on the specificity and scope of its claims.
3. What is the typical lifespan of such pharmaceutical patents in Korea?
20 years from the filing date, with possibilities for extensions in certain circumstances, such as patent term adjustments for regulatory delays.
4. How can patent holders leverage this patent for commercial advantage?
Through licensing, partnership, or exclusive commercialization rights, especially if the patent covers a novel therapeutic method or formulation with strong clinical data.
5. Are there any ongoing litigations or disputes related to KR102153143?
No publicly available information suggests current litigation; however, patent landscapes often involve patent oppositions or infringement disputes which should be monitored.
References
- Korean Intellectual Property Office (KIPO) Patent Database.
- Patent family data and global patent filings associated with KR102153143.
- Analysis of South Korean pharmaceutical patent trends (e.g., KIPO annual reports).
- Details on patent enforcement strategies in South Korea’s biotech and pharmaceutical sectors.
- Comparative patent analysis in the pharmaceutical domain.
Disclaimer: All specific patent details such as filing dates, assignee, and claims content are hypothetical or generalized examples. For exact legal or technical insights, consult the official patent document and relevant legal professionals.
